Table 3.
Variable | HR | 95% CI | P value |
---|---|---|---|
No XRT | 1.00 | Reference | <0.001 |
Adjuvant XRT | 0.67 | 0.64–0.71 | |
Age | |||
≤60 | 1.00 | Reference | <0.001 |
>60 | 1.49 | 1.42–1.57 | |
Gender | |||
Male | 1.00 | Reference | <0.001 |
Female | 0.88 | 0.84–0.91 | |
Race | |||
White | 1.00 | Reference | |
Black | 1.06 | 0.99–1.13 | 0.075 |
Other | 0.77 | 0.73–0.81 | <0.001 |
Lymph nodes | |||
LN <15 : >25 | 0.65 | 0.60–0.69 | <0.001 |
LN 15–26 : >25 | 0.84 | 0.78–0.91 | <0.001 |
Stage | |||
IA | 1.00 | Reference | |
IB | 1.689 | 1.55–1.84 | 0.004 |
II | 3.08 | 2.84–3.35 | <0.001 |
IIIA | 4.44 | 4.08–4.83 | <0.001 |
IIIB | 6.02 | 5.34–6.78 | 0.003 |
IV (M0) | 7.14 | 6.52–7.82 | <0.001 |